SmallCapFirm
Today's New Profile
(PURA) Has
Analyst
$.35 Price Target
*Major News All Week
Puts This Stock In The Limelight*
September 26th
Good Morning,
The morning is here and the markets open shortly. Let me ask, what
do you know about
Can*na*bis (CB) infused
beverages?
If it isn't much, that's okay, but I'm going to let you in on a
little tip...
It's time to educate
yourself!
CB-infused drinks could become
THE disruptors of the
beverage industry.
Between the passing of the
2018 US Farm Bill ,
and the idea of using it as a potential
health supplement ,
hemp-derived CB has witnessed an
explosive growth in
consumer interest over the past few years.
*2019 & Beyond... CB
Sales Growth Looks BIG*
Recreation and medical CB sales are posed to skyrocket. Some
predictions show sales to be in the neighborhood of
$11.7Bn this year
with potential growth to
$25Bn in 7 more
years.
Now, compare those figures with the
$38Bn in U.S. beer
sales last year. You can understand why both established beverage
companies and beverage entrepreneurs are taking a closer look at
methods and formulas for infusing CB into beverages.
The new profile I'm bringing to your attention for today is already
receiving serious notoriety for their CB-infused energy water that
is making the rounds.
And just this week, they dropped potentially game-changing news
regarding their new tea,
TranquiliTeaCBD
.
This company is making moves. That's why you need to get 9/26's
breakout idea,
Puration, Inc.
(PURA) , on your radar as they have a load of catalyst news this
week.
*PURA's Monster Sales
Making Serious Noise*
Last year (2018), PURA produced over
$1Mn in CB beverages
in the United States.
In only 6 months of 2019, Puration is reporting over
$1Mn in CB beverage
sales. That's
87% growth over the
first six months of sales in 2018.
Talk About A Giant
Leap!
Targeting
$4Mn in 2019 sales,
PURA doesn't appear to want to take the foot off the gas.
When it comes to companies producing CB-infused products, Puration
is not one to sleep on. Just look at
all the news they are
flinging at us this week!
Additionally, just yesterday, these sales figures have allowed Rob
Goldman, of Goldman Small Cap Research, confidence to provide this
stock with a spectacular
$.35 price
target .
Holy Moly...
From yesterday's closing trading level (approx. $.0849), PURA could
be packing potential upside of almost
312% !
*312% Potential Upside
May Be The Cards?*
From the $.0849 valuation, PURA may actually represent a stock with
312% in upside
potential!
Now, here's why $.35 could become a
stunning
reality while only in the short-term...
Company Catalyst #1.
Demand Is So Strong, PURA Opened a 2nd Plant.
PURA has been contending with an enviable problem; demand is high
and growing but production has not kept up. The new capacity
utilization should essentially double its previous production
capability.
Company Catalyst #2.
PURA Is the Best Positioned CB-infused Provider.
Much has been made of the recent FDA comments regarding CB-infused
products. (More on that later.) In the meantime, the bulk of PURA
sales are in the South/Southwest regions. This is key because some
southern states are designing their own regulatory guidelines to
foster sales, potentially bypassing the FDA. These events should
put also pressure on the FDA to act.
Company Catalyst #3. The
NOUV Dividend Transaction Is a Sweetener.
The NOUV transaction is a very good deal for PURA shareholders, and
upon completion adds meaningful value to PURA’s stock. Based on the
current market cap, we believe PURA’s current share price does not
reflect this hidden value.
Company Catalyst #4.
Sales Estimates Likely Too Low; M&A on the Way?
Given the big increase in production capacity, sales projections
for 2019 could be low and sales growth next year could be further
bolstered by M&A—which would leverage PURA’s early mover
infrastructure, sales, and its current formulation advantages. A
critical mass of sales from M&A could in turn make PURA a
future buyout candidate, once all of the FDA’s future CB-related
guidelines are implemented.
-----
*PURA's Recent Uptick
Signals Bigger Move?*
Towards the end of last week, PURA announced a
multitude of press
releases would be unleashed through this current week. At the
moment that happened, this stock started to
grow rapidly .
Since the announcement, daily shares traded averages have grown
significantly, while PURA's PPS rushed
110.42% from an open
of $.047 on 9/17 to Tuesday's high of $.0989.
Triple-digit short-term moves are nothing to ignore. I mean, just
check out the potential on
PURA's smoking hot
chart :
